Influence of Anesthetic Agents and the Perioperative Period on Cancer Recurrence and Metastasis
DOI:
https://doi.org/10.46328/ijonest.235Keywords:
The perioperative period, Anesthetic agents, Cancer, CA15-3, ImmunoassayAbstract
Cancer remains a leading cause of death worldwide, with its burden expected to increase, particularly in aging populations. The perioperative period and anesthetic techniques used during cancer surgeries are increasingly recognized as factors that may influence cancer recurrence and metastasis. This study investigates the impact of anesthetic agents and perioperative management on cancer outcomes in Iraqi patients. This study involved 68 Iraqi patients (42 males and 26 females) with various types of cancer, including prostate, colorectal, bladder, lung, cervical, breast, and ovarian cancers. The patients underwent surgery under general anesthesia, with follow-up assessments focusing on cancer recurrence, metastasis, and mortality rates. Serum levels of Cancer Antigen 15-3 (CA15-3) were measured using the VIDAS® immunoassay technique. Data were statistically analyzed using SPSS version 24, with results expressed as mean, standard deviation, and p-values. The study found a higher mortality rate in male patients (54%) compared to females (46%), with survival rates significantly higher in females. Cancer recurrence was observed in 46% of males and 43% of females. Serum levels of CA15-3 were significantly elevated in both male (77.97±2.44 kU/l) and female (96.33±3.66 kU/l) patients, indicating its potential as a diagnostic marker for cancer recurrence and metastasis. The results suggest that anesthetic agents, through their direct and indirect effects on tumor cells and the immune system, may influence cancer progression and patient outcomes. This study highlights the importance of considering anesthetic techniques and perioperative management in cancer surgeries to minimize the risk of recurrence and metastasis. The findings suggest that elevated CA15-3 levels could serve as a valuable biomarker for monitoring cancer recurrence. Further research is needed to explore the mechanisms by which anesthetic agents and perioperative factors contribute to cancer outcomes, potentially leading to improved perioperative protocols for cancer patients.Downloads
Published
Issue
Section
License
Copyright (c) 2024 International Journal on Engineering, Science and Technology
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Articles may be used for research, teaching, and private study purposes. Authors alone are responsible for the contents of their articles. The journal owns the copyright of the articles. The publisher shall not be liable for any loss, actions, claims, proceedings, demand, or costs or damages whatsoever or howsoever caused arising directly or indirectly in connection with or arising out of the use of the research material.
The author(s) of a manuscript agree that if the manuscript is accepted for publication in the International Journal on Engineering, Science and Technology (IJonEST), the published article will be copyrighted using a Creative Commons “Attribution 4.0 International” license. This license allows others to freely copy, distribute, and display the copyrighted work, and derivative works based upon it, under certain specified conditions.
Authors are responsible for obtaining written permission to include any images or artwork for which they do not hold copyright in their articles, or to adapt any such images or artwork for inclusion in their articles. The copyright holder must be made explicitly aware that the image(s) or artwork will be made freely available online as part of the article under a Creative Commons “Attribution 4.0 International” license.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
